Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02379 | Beta-D-Glucose | 1 | Withdrawn | 1 |
| DB00262 | Carmustine | 1 | Withdrawn | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Terminated | 2 |
| DB00987 | Cytarabine | 1 | Withdrawn | 1 |
| DB00773 | Etoposide | 1 | Withdrawn | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Terminated | 2 |
| DB16582 | Lisocabtagene maraleucel | 1 | Recruiting | 1 |
| DB16222 | Loncastuximab tesirine | 1 | Withdrawn | 1 |
| DB00888 | Mechlorethamine | 1 | Withdrawn | 1 |
| DB02379 | Beta-D-Glucose | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB01181 | Ifosfamide | 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 2 | Recruiting | 1 |
| DB18441 | Maplirpacept | 2 | Recruiting | 1 |
| DB17116 | Ontorpacept | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB15044 | Tafasitamab | 2 | Recruiting | 1 |
| DB15035 | Zanubrutinib | 2 | Recruiting | 1 |